{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:27:50Z","timestamp":1786750070224,"version":"build-2736575974"},"reference-count":84,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Soc Psychiatry"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>People living with schizophrenia often experience high levels of stigma and are consistently at risk of internalizing it. Internalized stigma has a negative impact on several clinical and recovery outcomes in people with schizophrenia, but the effect of internalized stigma on important patient reported outcomes that are gaining increasing scientific and clinical relevance, such as life engagement, has not yet been extensively investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study aims to investigate the relationship between several different socio-demographic, clinical, functional and medication-related variables and life engagement, with the hypothesis that internalized stigma, alongside other factors, could represent an individual predictor of reduced life engagement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Ninety-four participants diagnosed with schizophrenia were included in this cross-sectional study and were investigated with validated instruments assessing life engagement, schizophrenia symptoms severity, global clinical severity, internalized stigma, psychosocial functioning, antipsychotic-related side effects, attitude toward medications, and subjective well-being. Predictors of life engagement were assessed using a stepwise multivariate linear regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Greater global clinical severity (\u03b2\u2009=\u2009.685,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u2009.001), fewer years of education (\u03b2\u2009=\u2009\u2212.240,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u2009.001), and greater stigma endorsement (\u03b2\u2009=\u2009.180,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u2009.005) emerged as individual predictors of reduced patient life engagement, explaining a large proportion of the observed variance (Adjusted\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u2009.649,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Internalized stigma, among other well-recognized variables, appears to represent an individual predictor of worse patient life engagement in people living with schizophrenia. This finding should strengthen the notion that stigma, and internalized stigma in particular, represent important dimensions and treatment targets in the clinical management of schizophrenia, also in the perspective of improving patient-reported outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00207640261424408","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:51:54Z","timestamp":1773226314000},"page":"1439-1448","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Internalized Stigma Predicts Life Engagement in People With Schizophrenia: A Cross-Sectional Observational Study in a Real-World Setting"],"prefix":"10.1177","volume":"72","author":[{"given":"Stefano","family":"Barlati","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Italy"},{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7570-2195","authenticated-orcid":false,"given":"Gabriele","family":"Nibbio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bertoni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Calzavara-Pinton","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Morena","sequence":"additional","affiliation":[{"name":"Department of Anatomical, Histological, Forensic and Orthopedic Science, Sapienza University of Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Necchini","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Paolini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Baglioni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Zardini","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Poddighe","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Lisoni","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Deste","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Italy"},{"name":"Psychiatric Unit, Department of Mental Health and Addiction Services, ASST Valcamonica, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, ON, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vita","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Italy"},{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Ahad A. A. Sanchez-Gonzalez M. Junquera P. (2023). Understanding and addressing mental health stigma across cultures for improving psychiatric care: A narrative review. Cureus 15(5) e39549. https:\/\/doi.org\/10.7759\/cureus.39549","DOI":"10.7759\/cureus.39549"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","unstructured":"Austin P. C. Steyerberg E. W. (2015). The number of subjects per variable required in linear regression analyses. Journal of Clinical Epidemiology 68(6) 627\u2013636. https:\/\/doi.org\/10.1016\/j.jclinepi.2014.12.014","DOI":"10.1016\/j.jclinepi.2014.12.014"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"Barlati S. Morena D. Nibbio G. Cacciani P. Corsini P. Mosca A. Deste G. Accardo V. Turrina C. Valsecchi P. Vita A. (2022). Internalized stigma among people with schizophrenia: Relationship with socio-demographic clinical and medication-related features. Schizophrenia Research 243 364\u2013371. https:\/\/doi.org\/10.1016\/j.schres.2021.06.007","DOI":"10.1016\/j.schres.2021.06.007"},{"key":"e_1_3_3_5_1","doi-asserted-by":"crossref","unstructured":"Barlati S. Nibbio G. Morena D. Cacciani P. Corsini P. Mosca A. Deste G. Accardo V. Regina V. Lisoni J. Turrina C. Valsecchi P. Vita A. (2022). Autistic symptoms in schizophrenia: Impact on internalized stigma well-being clinical and functional characteristics. Frontiers in Psychiatry 13 801651. https:\/\/doi.org\/10.3389\/fpsyt.2022.801651","DOI":"10.3389\/fpsyt.2022.801651"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Barlati S. Nibbio G. Stanga V. Giovannoli G. Calzavara-Pinton I. Necchini N. Lisoni J. Deste G. Vita A. (2023). Cognitive and clinical characteristics of offenders and non-offenders diagnosed with schizophrenia spectrum disorders: Results of the recoviwel observational study. European Archives of Psychiatry and Clinical Neuroscience 273(6) 1307\u20131316. https:\/\/doi.org\/10.1007\/s00406-022-01510-9","DOI":"10.1007\/s00406-022-01510-9"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Barlati S. Nibbio G. Vita A. (2024). Evidence-based psychosocial interventions in schizophrenia: A critical review. Current Opinion in Psychiatry 37(3) 131\u2013139. https:\/\/doi.org\/10.1097\/YCO.0000000000000925","DOI":"10.1097\/YCO.0000000000000925"},{"key":"e_1_3_3_8_1","doi-asserted-by":"crossref","unstructured":"Barnes T. R. (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry 154(5) 672\u2013676. https:\/\/doi.org\/10.1192\/bjp.154.5.672","DOI":"10.1192\/bjp.154.5.672"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Bartr\u00e9s-Faz D. Cattaneo G. Solana J. Tormos J. M. Pascual-Leone A. (2018). Meaning in life: Resilience beyond reserve. Alzheimer\u2018s Research & Therapy 10(1) 47. https:\/\/doi.org\/10.1186\/s13195-018-0381-z","DOI":"10.1186\/s13195-018-0381-z"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"Boyd J. E. Adler E. P. Otilingam P. G. Peters T. (2014). Internalized stigma of mental illness (ISMI) scale: A multinational review. Comprehensive Psychiatry 55(1) 221\u2013231. https:\/\/doi.org\/10.1016\/j.comppsych.2013.06.005","DOI":"10.1016\/j.comppsych.2013.06.005"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"C\u00e1mara S. Contador I. Herrero P. Ruisoto P. S\u00e1nchez A. Cuellar L. L\u00f3pez R. Fournier M. C. Ramos F. (2021). The role of education in executive functions behavioral problems and functional performance in people with schizophrenia. Neuropsychology 35(4) 366\u2013373. https:\/\/doi.org\/10.1037\/neu0000679","DOI":"10.1037\/neu0000679"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Caqueo-Ur\u00edzar A. Ponce-Correa F. Urz\u00faa A. (2022). Effects of recovery measures on internalized stigma in patients diagnosed with schizophrenia. International Journal of Mental Health and Addiction 20(6) 3339\u20133355. https:\/\/doi.org\/10.1007\/s11469-022-00847-5","DOI":"10.1007\/s11469-022-00847-5"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Carrara B. S. Ventura C. A. A. (2018). Self-stigma mentally ill persons and health services: An integrative review of literature. Archives of Psychiatric Nursing 32(2) 317\u2013324. https:\/\/doi.org\/10.1016\/j.apnu.2017.11.001","DOI":"10.1016\/j.apnu.2017.11.001"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"Cerati C. Calzavara-Pinton I. Nibbio G. Cicale A. Zardini D. Italia M. Altieri L. Lisoni J. Deste G. Barlati S. Vita A. (2024). Different modalities of measuring life engagement in people living with schizophrenia spectrum disorders: A preliminary analysis. European Psychiatry 67(1) S211\u2013S212. https:\/\/doi.org\/10.1192\/j.eurpsy.2024.454","DOI":"10.1192\/j.eurpsy.2024.454"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Chan J. K. N. Correll C. U. Wong C. S. M. Chu R. S. T. Fung V. S. C. Wong G. H. S. Lei J. H. C. Chang W. C. (2023). Life expectancy and years of potential life lost in people with mental disorders: A systematic review and meta-analysis. eClinicalMedicine 65 102294. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102294","DOI":"10.1016\/j.eclinm.2023.102294"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","unstructured":"Correll C. U. Ismail Z. McIntyre R. S. Rafeyan R. Thase M. E. (2022). Patient functioning life engagement and treatment goals in major depressive disorder. Journal of Clinical Psychiatry 83(5) 42627. https:\/\/doi.org\/10.4088\/JCP.LU21112AH3","DOI":"10.4088\/JCP.LU21112AH3"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Correll C. U. Solmi M. Croatto G. Schneider L. K. Rohani-Montez S. C. Fairley L. Smith N. Bitter I. Gorwood P. Taipale H. Tiihonen J. (2022). Mortality in people with schizophrenia: A systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry 21(2) 248\u2013271. https:\/\/doi.org\/10.1002\/wps.20994","DOI":"10.1002\/wps.20994"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","unstructured":"Corrigan P. W. Rao D. (2012). On the self-stigma of mental illness: Stages disclosure and strategies for change. Canadian Journal of Psychiatry 57(8) 464\u2013469. https:\/\/doi.org\/10.1177\/070674371205700804.","DOI":"10.1177\/070674371205700804"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","unstructured":"de Bienassis K. Kristensen S. Hewlett E. Roe D. Mainz J. Klazinga N. (2021). Patient-reported indicators in mental health care: Towards international standards among members of the OECD. International Journal for Quality in Health Care 34(1) ii7\u2013ii12. https:\/\/doi.org\/10.1093\/intqhc\/mzab020","DOI":"10.1093\/intqhc\/mzab020"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","unstructured":"Degnan A. Berry K. Humphrey C. Bucci S. (2021). The relationship between stigma and subjective quality of life in psychosis: A systematic review and meta-analysis. Clinical Psychology Review 85 102003. https:\/\/doi.org\/10.1016\/j.cpr.2021.102003","DOI":"10.1016\/j.cpr.2021.102003"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Deste G. Kakli M. Barlati S. Nibbio G. Dossou P. Degila S. L. Ceraso A. Lisoni J. Calzavara-Pinton I. Villa S. Vita A. (2024). Application of cognitive remediation in the world: New experiences from two schizophrenia rehabilitation centers in Togo and Benin. Social Psychiatry and Psychiatric Epidemiology 59(10) 1775\u20131783. https:\/\/doi.org\/10.1007\/s00127-023-02603-z","DOI":"10.1007\/s00127-023-02603-z"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","unstructured":"Deste G. Vita A. Nibbio G. Penn D. L. Pinkham A. E. Harvey P. D. (2020). Autistic symptoms and social cognition predict real-world outcomes in patients with schizophrenia. Frontiers in Psychiatry 11 524. https:\/\/doi.org\/10.3389\/fpsyt.2020.00524","DOI":"10.3389\/fpsyt.2020.00524"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Dickerson F. Khan S. Origoni A. Rowe K. Katsafanas E. Harvin A. Yang S. Yolken R. (2024). Risk factors for natural cause mortality in schizophrenia. JAMA Network Open 7(9) e2432401. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.32401","DOI":"10.1001\/jamanetworkopen.2024.32401"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","unstructured":"Dubreucq J. Plasse J. Franck N. (2021). Self-stigma in serious mental illness: A systematic review of frequency correlates and consequences. Schizophrenia Bulletin 47(5) 1261\u20131287. https:\/\/doi.org\/10.1093\/schbul\/sbaa181","DOI":"10.1093\/schbul\/sbaa181"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","unstructured":"Gagiu C. Dionisie V. Manea M. C. Mazilu D. C. Manea M. (2024). Internalised stigma self-esteem and perceived social support as psychosocial predictors of quality of life in adult patients with schizophrenia. Journal of Clinical Medicine 13(22) 6959. https:\/\/doi.org\/10.3390\/jcm13226959","DOI":"10.3390\/jcm13226959"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","unstructured":"Galderisi S. Rossi A. Rocca P. Bertolino A. Mucci A. Bucci P. Rucci P. Gibertoni D. Aguglia E. Amore M. Bellomo A. Biondi M. Brugnoli R. Dell\u2019Osso L. De Ronchi D. Di Emidio G. Di Giannantonio M. Fagiolini A. Marchesi C. . . . Maj M. (2014). The influence of illness-related variables personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry 13(3) 275\u2013287. https:\/\/doi.org\/10.1002\/wps.20167","DOI":"10.1002\/wps.20167"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","unstructured":"Galderisi S. Rucci P. Kirkpatrick B. Mucci A. Gibertoni D. Rocca P. Rossi A. Bertolino A. Strauss G. P. Aguglia E. Bellomo A. Murri M. B. Bucci P. Carpiniello B. Comparelli A. Cuomo A. De Berardis D. Dell\u2019Osso L. Di Fabio F. Maj M. (2018). Interplay among psychopathologic variables personal resources context-related factors and real-life functioning in individuals with schizophrenia: A network analysis. JAMA Psychiatry 75(4) 396\u2013404. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.4607","DOI":"10.1001\/jamapsychiatry.2017.4607"},{"key":"e_1_3_3_28_1","doi-asserted-by":"crossref","unstructured":"Galderisi S. Rucci P. Mucci A. Rossi A. Rocca P. Bertolino A. Aguglia E. Amore M. Bellomo A. Bozzatello P. Bucci P. Carpiniello B. Collantoni E. Cuomo A. Dell\u2019Osso L. Di Fabio F. di Giannantonio M. Gibertoni D. Giordano G. M. . . . Maj M. (2020). The interplay among psychopathology personal resources context-related factors and real-life functioning in schizophrenia: Stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients. World Psychiatry 19(1) 81\u201391. https:\/\/doi.org\/10.1002\/wps.20700","DOI":"10.1002\/wps.20700"},{"key":"e_1_3_3_29_1","doi-asserted-by":"crossref","unstructured":"Gerlinger G. Hauser M. De Hert M. Lacluyse K. Wampers M. Correll C. U. (2013). Personal stigma in schizophrenia spectrum disorders: A systematic review of prevalence rates correlates impact and interventions. World Psychiatry 12(2) 155\u2013164. https:\/\/doi.org\/10.1002\/wps.20040","DOI":"10.1002\/wps.20040"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","unstructured":"Germain N. Kymes S. L\u00f6f E. Jakubowska A. Fran\u00e7ois C. Weatherall J. (2019). A systematic literature review identifying associations between outcomes and quality of life (QoL) or healthcare resource utilization (HCRU) in schizophrenia. Journal of Medical Economics 22(5) 403\u2013413. https:\/\/doi.org\/10.1080\/13696998.2019.1576694","DOI":"10.1080\/13696998.2019.1576694"},{"key":"e_1_3_3_31_1","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy W.","year":"1976","unstructured":"Guy W. (1976). ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare, Public Health Service."},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","unstructured":"Harvey P. D. Bosia M. Cavallaro R. Howes O. D. Kahn R. S. Leucht S. M\u00fcller D. R. Penad\u00e9s R. Vita A. (2022). Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art. Schizophrenia Research Cognition 29 100249. https:\/\/doi.org\/10.1016\/j.scog.2022.100249","DOI":"10.1016\/j.scog.2022.100249"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","unstructured":"Harvey P. D. Strassnig M. (2012). Predicting the severity of everyday functional disability in people with schizophrenia: Cognitive deficits functional capacity symptoms and health status. World Psychiatry: Official Journal of the World Psychiatric Association (WPA) 11(2) 73\u201379. https:\/\/doi.org\/10.1016\/j.wpsyc.2012.05.004","DOI":"10.1016\/j.wpsyc.2012.05.004"},{"key":"e_1_3_3_34_1","doi-asserted-by":"crossref","unstructured":"Heinze G. Wallisch C. Dunkler D. (2018). Variable selection - A review and recommendations for the practicing statistician. Biometrical journal. Biometrische Zeitschrift 60(3) 431\u2013449. https:\/\/doi.org\/10.1002\/bimj.201700067","DOI":"10.1002\/bimj.201700067"},{"key":"e_1_3_3_35_1","doi-asserted-by":"crossref","unstructured":"Herrero P. Contador I. Stern Y. Fern\u00e1ndez-Calvo B. S\u00e1nchez A. Ramos F. (2020). Influence of cognitive reserve in schizophrenia: A systematic review. Neuroscience and Biobehavioral Reviews 108 149\u2013159. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.10.019","DOI":"10.1016\/j.neubiorev.2019.10.019"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","unstructured":"Hogan T. P. Awad A. G. Eastwood R. (1983). A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine 13(1) 177\u2013183. https:\/\/doi.org\/10.1017\/S0033291700050182","DOI":"10.1017\/S0033291700050182"},{"key":"e_1_3_3_37_1","doi-asserted-by":"crossref","unstructured":"Ismail Z. Meehan S. R. Farovik A. Kapadia S. Palma A. M. Zhang Z. McIntyre R. S. (2025). Effects of brexpiprazole on patient life engagement in schizophrenia: Post hoc analysis of positive and negative syndrome scale data. Current Medical Research and Opinion 41(1) 145\u2013153. https:\/\/doi.org\/10.1080\/03007995.2024.2440059","DOI":"10.1080\/03007995.2024.2440059"},{"key":"e_1_3_3_38_1","doi-asserted-by":"crossref","unstructured":"Ismail Z. Meehan S. R. Farovik A. Miguelez M. Kapadia S. Regnier S. A. Zhang Z. Brown T. M. Milien M. McIntyre R. S. (2024). Assessment of patient life engagement in schizophrenia using items from the positive and negative syndrome scale. Schizophrenia Research 274 337\u2013344. https:\/\/doi.org\/10.1016\/j.schres.2024.10.008","DOI":"10.1016\/j.schres.2024.10.008"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","unstructured":"Jagan S. Mohd Daud T. I. Chia L. C. Saini S. M. Midin M. Eng-Teng N. Ratnasingam S. (2023). Evidence for the effectiveness of psychological interventions for internalized stigma among adults with schizophrenia spectrum disorders: A systematic review and meta-analyses. International Journal of Environmental Research and Public Health 20(8) 5570. https:\/\/doi.org\/10.3390\/ijerph20085570","DOI":"10.3390\/ijerph20085570"},{"key":"e_1_3_3_40_1","doi-asserted-by":"crossref","unstructured":"Jefferson A. L. Gibbons L. E. Rentz D. M. Carvalho J. O. Manly J. Bennett D. A. Jones R. N. (2011). A life course model of cognitive activities socioeconomic status education reading ability and cognition. Journal of the American Geriatrics Society 59(8) 1403\u20131411. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03499.x","DOI":"10.1111\/j.1532-5415.2011.03499.x"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","unstructured":"Jian C. R. Wang P. W. Lin H. C. Huang M. F. Yeh Y. C. Liu T. L. Chen C. S. Lin Y. P. Lee S. Y. Chen C. H. Wang Y. C. Chang Y. P. Chen Y. L. Yen C. F. (2022). Association between self-stigma and suicide risk in individuals with schizophrenia: Moderating effects of self-esteem and perceived support from friends. International Journal of Environmental Research and Public Health 19(22) 15071. https:\/\/doi.org\/10.3390\/ijerph192215071","DOI":"10.3390\/ijerph192215071"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","unstructured":"Jones S. H. Thornicroft G. Coffey M. Dunn G. (1995). A brief mental health outcome scale-reliability and validity of the global assessment of functioning (GAF). British Journal of Psychiatry 166(5) 654\u2013659. https:\/\/doi.org\/10.1192\/bjp.166.5.654","DOI":"10.1192\/bjp.166.5.654"},{"key":"e_1_3_3_43_1","doi-asserted-by":"crossref","unstructured":"Kay S. R. Fiszbein A. Opler L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13(2) 261\u2013276. https:\/\/doi.org\/10.1093\/schbul\/13.2.261","DOI":"10.1093\/schbul\/13.2.261"},{"key":"e_1_3_3_44_1","doi-asserted-by":"crossref","unstructured":"Keepers G. A. Fochtmann L. J. Anzia J. M. Benjamin S. Lyness J. M. Mojtabai R. Servis M. Walaszek A. Buckley P. Lenzenweger M. F. Young A. S. Degenhardt A. Hong S. H. (2020). The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry 177(9) 868\u2013872. https:\/\/doi.org\/10.1176\/appi.ajp.2020.177901","DOI":"10.1176\/appi.ajp.2020.177901"},{"key":"e_1_3_3_45_1","doi-asserted-by":"crossref","unstructured":"Kieffer C. M. Miller A. R. Chacko B. Robertson A. S. (2020). FDA reported use of patient experience data in 2018 drug approvals. Therapeutic Innovation & Regulatory Science 54(3) 709\u2013716. https:\/\/doi.org\/10.1007\/s43441-019-00106-1","DOI":"10.1007\/s43441-019-00106-1"},{"key":"e_1_3_3_46_1","doi-asserted-by":"crossref","unstructured":"Lamarca M. Espinosa V. Acu\u00f1a V. Vila-Badia R. Balsells-Mejia S. Moritz S. Berna F. K\u00f6nig C. Gaw\u0119da \u0141. Group P. Barajas A. Ochoa S. (2024). Reducing self-stigma in psychosis: A systematic review and meta-analysis of psychological interventions. Psychiatry Research 342 116262. https:\/\/doi.org\/10.1016\/j.psychres.2024.116262","DOI":"10.1016\/j.psychres.2024.116262"},{"key":"e_1_3_3_47_1","doi-asserted-by":"crossref","unstructured":"Lingj\u00e6rde O. Ahlfors U. G. Bech P. Dencker S. J. Elgen K. (1987). The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica. Supplementum 76 1\u2013100. https:\/\/doi.org\/10.1111\/j.1600-0447.1987.tb10566.x","DOI":"10.1111\/j.1600-0447.1987.tb10566.x"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.soc.27.1.363"},{"key":"e_1_3_3_49_1","doi-asserted-by":"crossref","unstructured":"Liu N. H. Daumit G. L. Dua T. Aquila R. Charlson F. Cuijpers P. Druss B. Dudek K. Freeman M. Fujii C. Gaebel W. Hegerl U. Levav I. Munk Laursen T. Ma H. Maj M. Elena Medina-Mora M. Nordentoft M. Prabhakaran D. Saxena S. (2017). Excess mortality in persons with severe mental disorders: A multilevel intervention framework and priorities for clinical practice policy and research agendas. World Psychiatry 16(1) 30\u201340. https:\/\/doi.org\/10.1002\/wps.20384","DOI":"10.1002\/wps.20384"},{"key":"e_1_3_3_50_1","doi-asserted-by":"crossref","unstructured":"Livingston J. D. Boyd J. E. (2010). Correlates and consequences of internalized stigma for people living with mental illness: A systematic review and meta-analysis. Social Science & Medicine 71(12) 2150\u20132161. https:\/\/doi.org\/10.1016\/j.socscimed.2010.09.0301982.","DOI":"10.1016\/j.socscimed.2010.09.030"},{"key":"e_1_3_3_51_1","doi-asserted-by":"crossref","unstructured":"Maj M. van Os J. De Hert M. Gaebel W. Galderisi S. Green M. F. Guloksuz S. Harvey P. D. Jones P. B. Malaspina D. McGorry P. Miettunen J. Murray R. M. Nuechterlein K. H. Peralta V. Thornicroft G. van Winkel R. Ventura J. (2021). The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry 20(1) 4\u201333. https:\/\/doi.org\/10.1002\/wps.20809","DOI":"10.1002\/wps.20809"},{"key":"e_1_3_3_52_1","doi-asserted-by":"crossref","unstructured":"McCutcheon R. A. Keefe R. S. E. McGuire P. K. (2023). Cognitive impairment in schizophrenia: Aetiology pathophysiology and treatment. Molecular Psychiatry 28(5) 1902\u20131918. https:\/\/doi.org\/10.1038\/s41380-023-01949-9","DOI":"10.1038\/s41380-023-01949-9"},{"key":"e_1_3_3_53_1","doi-asserted-by":"crossref","unstructured":"McIntyre R. S. Ismail Z. Watling C. P. Weiss C. Meehan S. R. Musingarimi P. Thase M. E. (2022). Patient-reported outcome measures for life engagement in mental health: A systematic review. Journal of Patient-Reported Outcomes 6(1) 62. https:\/\/doi.org\/10.1186\/s41687-022-00468-5","DOI":"10.1186\/s41687-022-00468-5"},{"key":"e_1_3_3_54_1","doi-asserted-by":"crossref","unstructured":"Misra S. Jackson V. W. Chong J. Choe K. Tay C. Wong J. Yang L. H. (2021). Systematic review of cultural aspects of stigma and mental illness among racial and ethnic minority groups in the United States: Implications for interventions. American Journal of Community Psychology 68(3-4) 486\u2013512. https:\/\/doi.org\/10.1002\/ajcp.12516","DOI":"10.1002\/ajcp.12516"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(24)00376-6"},{"key":"e_1_3_3_56_1","doi-asserted-by":"crossref","unstructured":"Morgan A. J. Reavley N. J. Ross A. Too L. S. Jorm A. F. (2018). Interventions to reduce stigma towards people with severe mental illness: Systematic review and meta-analysis. Journal of Psychiatric Research 103 120\u2013133. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.05.017","DOI":"10.1016\/j.jpsychires.2018.05.017"},{"key":"e_1_3_3_57_1","doi-asserted-by":"crossref","unstructured":"Naber D. Moritz S. Lambert M. Pajonk F. G. Holzbach R. Mass R. Andresen B. (2001). Improvement of schizophrenic patients\u2019 subjective well-being under atypical antipsychotic drugs. Schizophrenia Research 50(1-2) 79\u201388. https:\/\/doi.org\/10.1016\/s0920-9964(00)00166-3","DOI":"10.1016\/S0920-9964(00)00166-3"},{"key":"e_1_3_3_58_1","doi-asserted-by":"crossref","unstructured":"Naber D. Vita A. (2004). Tools for measuring clinical effectiveness. European Neuropsychopharmacology 14 S435\u2013S444. https:\/\/doi.org\/10.1016\/j.euroneuro.2004.08.002","DOI":"10.1016\/j.euroneuro.2004.08.002"},{"key":"e_1_3_3_59_1","doi-asserted-by":"crossref","unstructured":"Onitsuka T. Hirano Y. Nakazawa T. Ichihashi K. Miura K. Inada K. Mitoma R. Yasui-Furukori N. Hashimoto R. (2022). Toward recovery in schizophrenia: Current concepts findings and future research directions. Psychiatry and Clinical Neurosciences 76(7) 282\u2013291. https:\/\/doi.org\/10.1111\/pcn.13342","DOI":"10.1111\/pcn.13342"},{"key":"e_1_3_3_60_1","doi-asserted-by":"crossref","unstructured":"Peritogiannis V. Ninou A. Samakouri M. (2022). Mortality in schizophrenia-spectrum disorders: Recent advances in understanding and management. Healthcare 10(12) 2366. https:\/\/doi.org\/10.3390\/healthcare10122366","DOI":"10.3390\/healthcare10122366"},{"key":"e_1_3_3_61_1","doi-asserted-by":"crossref","unstructured":"Ran M. S. Hall B. J. Su T. T. Prawira B. Breth-Petersen M. Li X. H. Zhang T. M. (2021). Stigma of mental illness and cultural factors in pacific rim region: A systematic review. BMC Psychiatry 21(1) 8. https:\/\/doi.org\/10.1186\/s12888-020-02991-5","DOI":"10.1186\/s12888-020-02991-5"},{"key":"e_1_3_3_62_1","doi-asserted-by":"crossref","unstructured":"Reinharth J. Reynolds G. Dill C. Serper M. (2014). Cognitive predictors of violence in schizophrenia: A meta-analytic review. Schizophrenia Research Cognition 1(2) 101\u2013111. https:\/\/doi.org\/10.1016\/j.scog.2014.06.001","DOI":"10.1016\/j.scog.2014.06.001"},{"key":"e_1_3_3_63_1","doi-asserted-by":"crossref","unstructured":"Ritsher J. B. Otilingam P. G. Grajales M. (2003). Internalized stigma of mental illness: Psychometric properties of a new measure. Psychiatry Research 121(1) 31\u201349. https:\/\/doi.org\/10.1016\/j.psychres.2003.08.008","DOI":"10.1016\/j.psychres.2003.08.008"},{"key":"e_1_3_3_64_1","doi-asserted-by":"crossref","unstructured":"Rossi A. Amore M. Galderisi S. Rocca P. Bertolino A. Aguglia E. Amodeo G. Bellomo A. Bucci P. Buzzanca A. Carpiniello B. Comparelli A. Dell\u2019Osso L. di Giannantonio M. Mancini M. Marchesi C. Monteleone P. Montemagni C. Oldani L. (2018). The complex relationship between self-reported \u2018personal recovery\u2019 and clinical recovery in schizophrenia. Schizophrenia Research 192 108\u2013112. https:\/\/doi.org\/10.1016\/j.schres.2017.04.040","DOI":"10.1016\/j.schres.2017.04.040"},{"key":"e_1_3_3_65_1","doi-asserted-by":"crossref","unstructured":"Sartorius N. (2014). Patient-reported outcomes in psychiatry. Dialogues in Clinical Neuroscience 16(2) 123\u2013124. https:\/\/doi.org\/10.31887\/DCNS.2014.16.2\/nsartorius","DOI":"10.31887\/DCNS.2014.16.2\/nsartorius"},{"key":"e_1_3_3_66_1","doi-asserted-by":"crossref","unstructured":"Scheier M. F. Wrosch C. Baum A. Cohen S. Martire L. M. Matthews K. A. Schulz R. Zdaniuk B. (2006). The life engagement test: Assessing purpose in life. Journal of Behavioral Medicine 29(3) 291\u2013298. https:\/\/doi.org\/10.1007\/s10865-005-9044-1","DOI":"10.1007\/s10865-005-9044-1"},{"key":"e_1_3_3_67_1","doi-asserted-by":"crossref","unstructured":"Schwarzbold M. L. Kern R. S. Novacek D. M. McGovern J. E. Catalano L. T. Green M. F. (2021). Self-stigma in psychotic disorders: Clinical cognitive and functional correlates in a diverse sample. Schizophrenia Research 228 145\u2013150. https:\/\/doi.org\/10.1016\/j.schres.2020.12.003","DOI":"10.1016\/j.schres.2020.12.003"},{"key":"e_1_3_3_68_1","doi-asserted-by":"crossref","unstructured":"Sharaf A. Y. Ossman L. H. Lachine O. A. (2012). A cross-sectional study of the relationships between illness insight internalized stigma and suicide risk in individuals with schizophrenia. International Journal of Nursing Studies 49(12) 1512\u20131520. https:\/\/doi.org\/10.1016\/j.ijnurstu.2012.08.006","DOI":"10.1016\/j.ijnurstu.2012.08.006"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.12691\/ajams-8-2-1"},{"key":"e_1_3_3_70_1","doi-asserted-by":"crossref","unstructured":"Simpson G. M. Angus J. W. S. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 212(S212) 11\u201319. https:\/\/doi.org\/10.1111\/j.1600-0447.1970.tb02066.x","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_3_3_71_1","doi-asserted-by":"crossref","unstructured":"Solmi M. Croatto G. Piva G. Rosson S. Fusar-Poli P. Rubio J. M. Carvalho A. F. Vieta E. Arango C. DeTore N. R. Eberlin E. S. Mueser K. T. Correll C. U. (2023). Efficacy and acceptability of psychosocial interventions in schizophrenia: Systematic overview and quality appraisal of the meta-analytic evidence. Molecular Psychiatry 28(1) 354\u2013368. https:\/\/doi.org\/10.1038\/s41380-022-01727-z","DOI":"10.1038\/s41380-022-01727-z"},{"key":"e_1_3_3_72_1","doi-asserted-by":"crossref","unstructured":"Tandon R. Nasrallah H. Akbarian S. Carpenter W. T.Jr DeLisi L. E Gaebel W Green M. F Gur R. E Heckers S Kane J. M Malaspina D Meyer-Lindenberg A Murray R Owen M Smoller J. W Yassin W Keshavan M. (2024). The schizophrenia syndrome circa 2024: What we know and how that informs its nature. Schizophrenia Research 264 1\u201328. https:\/\/doi.org\/10.1016\/j.schres.2023.11.015","DOI":"10.1016\/j.schres.2023.11.015"},{"key":"e_1_3_3_73_1","doi-asserted-by":"crossref","unstructured":"Thornicroft G. Sunkel C. Aliev A. A. Baker S. Brohan E. Chammay R. Davies K. Demissie M. Duncan J. Fekadu W. Gronholm P. C. Guerrero Z. Gurung D. Habtamu K. Hanlon C. Heim E. Henderson C. Hijazi Z. Hoffman C. Winkler P. (2022). The lancet commission on ending stigma and discrimination in mental health. Lancet 400(10361) 1438\u20131480. https:\/\/doi.org\/10.1016\/S0140-6736(22)01470-2","DOI":"10.1016\/S0140-6736(22)01470-2"},{"key":"e_1_3_3_74_1","doi-asserted-by":"crossref","unstructured":"Townsend M. Pareja K. Buchanan-Hughes A. Worthington E. Pritchett D. Brubaker M. Houle C. Mose T. N. Waters H. (2022). Antipsychotic-related stigma and the impact on treatment choices: A systematic review and framework synthesis. Patient Preference and Adherence 16 373\u2013401. https:\/\/doi.org\/10.2147\/PPA.S343211","DOI":"10.2147\/PPA.S343211"},{"key":"e_1_3_3_75_1","doi-asserted-by":"crossref","unstructured":"Trompetter H. R. Ten Klooster P. M. Schreurs K. M. G. Fledderus M. Westerhof G. J. Bohlmeijer E. T. (2013). Measuring values and committed action with the engaged living scale (ELS): Psychometric evaluation in a nonclinical sample and a chronic pain sample. Psychological Assessment 25(4) 1235\u20131246. https:\/\/doi.org\/10.1037\/a0033813","DOI":"10.1037\/a0033813"},{"key":"e_1_3_3_76_1","doi-asserted-by":"crossref","unstructured":"Veselinovi\u0107 T. Neuner I. (2022). Progress and pitfalls in developing agents to treat neurocognitive deficits associated with schizophrenia. CNS Drugs 36(8) 819\u2013858. https:\/\/doi.org\/10.1007\/s40263-022-00935-z","DOI":"10.1007\/s40263-022-00935-z"},{"key":"e_1_3_3_77_1","doi-asserted-by":"crossref","unstructured":"Vita A. Nibbio G. Barlati S. (2024a). Conceptualization and characterization of \u201cprimary\u201d and \u201csecondary\u201d cognitive impairment in schizophrenia. Psychiatry Research 340 116126. https:\/\/doi.org\/10.1016\/j.psychres.2024.116126","DOI":"10.1016\/j.psychres.2024.116126"},{"key":"e_1_3_3_78_1","doi-asserted-by":"crossref","unstructured":"Vita A. Nibbio G. Barlati S. (2024b). Pharmacological treatment of cognitive impairment associated with schizophrenia: State of the art and future perspectives. Schizophrenia Bulletin Open 5(1) sgae013. https:\/\/doi.org\/10.1093\/schizbullopen\/sgae013","DOI":"10.1093\/schizbullopen\/sgae013"},{"key":"e_1_3_3_79_1","doi-asserted-by":"crossref","unstructured":"Vita A. Barlati S. (2018). Recovery from schizophrenia: Is it possible? Current Opinion in Psychiatry 31(3) 246\u2013255. https:\/\/doi.org\/10.1097\/YCO.0000000000000407","DOI":"10.1097\/YCO.0000000000000407"},{"key":"e_1_3_3_80_1","doi-asserted-by":"crossref","unstructured":"Vita A. Barlati S. Ceraso A. Nibbio G. Durante F. Facchi M. Deste G. Wykes T. (2024). Durability of effects of cognitive remediation on cognition and psychosocial functioning in schizophrenia: A systematic review and meta-analysis of randomized clinical trials. American Journal of Psychiatry 181(6) 520\u2013531. https:\/\/doi.org\/10.1176\/appi.ajp.20230396","DOI":"10.1176\/appi.ajp.20230396"},{"key":"e_1_3_3_81_1","doi-asserted-by":"crossref","unstructured":"Vita A. Barlati S. Deste G. Nibbio G. Penn D. L. Pinkham A. E. McIntyre R. S. Harvey P. D. (2023). Life engagement in people living with schizophrenia: Predictors and correlates of patient life engagement in a large sample of people living in the community. Psychological Medicine 53(16) 7943\u20137952. https:\/\/doi.org\/10.1017\/s0033291723002106","DOI":"10.1017\/S0033291723002106"},{"key":"e_1_3_3_82_1","doi-asserted-by":"crossref","unstructured":"Weiss C. Meehan S. R. Brown T. M. Gupta C. M\u00f8rup M. F. Thase M. E. McIntyre R. S. Ismail Z. (2021). Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: Post hoc analysis of patient-reported outcomes from clinical trial exit interviews. Journal of Patient-Reported Outcomes 5(1) 128. https:\/\/doi.org\/10.1186\/s41687-021-00380-4","DOI":"10.1186\/s41687-021-00380-4"},{"key":"e_1_3_3_83_1","volume-title":"WHO collaborating centre for drug statistics methodology. ATC classification and DDD assignment","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. (2017). WHO collaborating centre for drug statistics methodology. ATC classification and DDD assignment. World Health Organization."},{"key":"e_1_3_3_84_1","doi-asserted-by":"crossref","unstructured":"Yanos P. T. DeLuca J. S. Roe D. Lysaker P. H. (2020). The impact of illness identity on recovery from severe mental illness: A review of the evidence. Psychiatry Research 288 112950. https:\/\/doi.org\/10.1016\/j.psychres.2020.112950.","DOI":"10.1016\/j.psychres.2020.112950"},{"key":"e_1_3_3_85_1","doi-asserted-by":"crossref","unstructured":"Yung N. C. L. Wong C. S. M. Chan J. K. N. Chen E. Y. H. Chang W. C. (2021). Excess mortality and life-years lost in people with schizophrenia and other non-affective psychoses: An 11-year population-based cohort study. Schizophrenia bulletin 47(2) 474\u2013484. https:\/\/doi.org\/10.1093\/schbul\/sbaa137","DOI":"10.1093\/schbul\/sbaa137"}],"container-title":["International Journal of Social Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00207640261424408","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00207640261424408","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00207640261424408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:20:11Z","timestamp":1786749611000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00207640261424408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/00207640261424408"],"URL":"https:\/\/doi.org\/10.1177\/00207640261424408","relation":{},"ISSN":["0020-7640","1741-2854"],"issn-type":[{"value":"0020-7640","type":"print"},{"value":"1741-2854","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}